Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
With their party gaining control of both the White House and Congress, some Republican voters are growing hesitant about outright abolition of the Affordable Care Act and instead favoring a more circumspect approach of scaling it back, according to a poll released Thursday.
Substantially more health plans on the federal insurance marketplaces require consumers next year to pay a hefty portion of the cost of the most expensive drugs, changes that analysts say are intended to deter persistently ill patients from choosing their policies.
Las Vegas resident Connie Densmore, a financial adviser and tax preparer, is used to dealing with technical terms and jargon.
President-elect Donald Trump is eager to change the nation’s health care law – and most Americans are eager for some changes, a new Gallup Poll released Monday found.
Newly unsealed court testimony shows health insurers Anthem Inc. andCigna Corp. have significant disagreements about their proposed merger, offering fresh details about a rift that is highly unusual for two companies seeking to press ahead with such a deal.
Republicans set on rapidly dismantling the Affordable Care Act are also pushing an overhaul of Medicaid, whose expansion under the 2010 law has covered millions of low-income Americans—many in states run by GOP governors.
It wasn’t so long ago that health insurance horror stories fueled discussions around the family dinner table and the national debate over health care reform.
President-elect Donald Trump and House Speaker Paul Ryan agree that repealing the Affordable Care Act and replacing it with some other health insurance system is a top priority.
In the furor over high drug prices, both Congress and the media have largely focused on the role played by drug companies such as Turing Pharmaceuticals, Valeant, and Mylan. Another contributor — pharmacy benefit managers and the rebates they get from drug companies — is only now getting the attention it deserves.
Senator Elizabeth Warren on Monday railed against legislation that would ease standards for new drugs and medical devices, saying the bill had been “hijacked” by the pharmaceutical industry.